mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.4 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.4 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.4 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |